Personalized nutrition is still in its infancy but it is an increasingly important area of research that may one day help us better plan nutritional interventions to ensure a better response from patients.
Personalized nutrition and gut microbiota to predict response to diet in obese and IBS patients
24 Jun 2019by Allison Clark
An individual’s gut microbiota composition might be used in predicting responses to dietary interventions. However, there’s still inconsistent evidence to support the existence of signature gut microbiota compositions that predict clinical response to diet in obese and IBS patients.
Irritable Bowel Syndrome – Symptoms, Treatment, Research: A video by ESNM
12 Jun 2019by GMFH Editing Team
In this video, the European Society of Neurogastroenterology & Motility (ESNM) explains how important it is for irritable bowel syndrome (IBS) to be diagnosed so it can then be treated correctly.
In irritable bowel syndrome, probiotic bacteria show promise for improving mood
5 Jul 2017by Heather Galipeau
A new study shows that a specific probiotic can help treat symptoms of depression in patients who suffer from irritable bowel syndrome (or IBS).
Researchers find the first evidence of brain structural alterations correlated with gut microbes in people with irritable bowel syndrome
29 May 2017by Andreu Prados
A new study has found that gut microbial composition may be associated with brain structural alterations in people with IBS.
Toward a better understanding of the link between irritable bowel syndrome and anxiety and depression
22 Mar 2017by Kristina Campbell
Many studies show that there is a link between patients with irritable bowel syndrome (IBS) and gut microbiota, revealing alterations in the people with this condition.
Researchers identify intestinal microbiota profile related to severity of IBS symptoms
21 Dec 2016by Andreu Prados
A recent study, led by Prof. Magnus Simrén from the Department of Internal Medicine & Clinical Nutrition and University of Gothenburg Centre for Person-Centered Care at the University of Gothenburg in Gothenburg (Sweden), has identified a gut microbiota profile that is related to the severity of IBS symptoms.
Studying how the low-FODMAP diet reduces symptoms in Irritable Bowel Syndrome
14 Sep 2016by Kristina Campbell
Foods that trigger symptoms are well identified by those who suffer from irritable bowel syndrome (IBS).
The oral microbiota as a potential source of information in irritable bowel syndrome
12 Sep 2016by Andreu Prados
A recent study, led by Dr. Wendy A. Henderson from the National Institute of Nursing Research at National Institutes of Health (NIH) in Bethesda (USA), and co-authored by Research Fellow Dr. Nicolaas Fourie, has found that the oral microbiota could be a useful source of information in patients with irritable bowel syndrome (IBS).
Irritable bowel syndrome (IBS) is one of the most common functional gastrointestinal disorders, affecting more than 10% of the population, with the highest impact in women. Although its origin is still unknown, reduced gut microbial diversity could be involved in its development.
